Sort
21,281 grants matching “influenza”
Development of a novel human rhinovirus vaccine
$298,345Gregory John Tobin · Biological Mimetics, Inc. · R43 · FY2010 · AI
Regulation of mRNA Export by Viral Proteins
$298,300Beatriz Marina Avila Fontoura · Ut Southwestern Medical Center · R01 · FY2008 · GM
Role of the NFkB signaling network in generating memory B cell and long-lived plasma cell
$298,292Koushik Roy · University Of Utah · R56 · FY2024 · AI
Metabolomics Core
$298,226Edward A Dennis · Icahn School Of Medicine At Mount Sinai · U19 · FY2017 · AI
Rapid, disposable, nucleic acid diagnostic device for multiplexed point of care f
$298,218Hong Cai · Mesa Tech International, Inc. · R43 · FY2011 · AI
Implementing Health Promotion Activities in Native Employers
$298,217Deborah J. Bowen · Boston University Medical Campus · R21 · FY2008 · CA
An Evaluation of Vaccination Practices of Nursing Home Residents and Staff
$298,209David H Howard · Emory University · U01 · FY2011 · IP
SLIT2N for the treatment of influenza-induced acute respiratory distress
$298,200Sutip Navankasattusas · Navigen, Inc. · R43 · FY2010 · AI
Microfluidic Viral Infection Assay
$298,181John Yin · Bellbrook Labs, Llc · R41 · FY2009 · AI
SOCIAL REORGANIZATION, HPA REACTIVITY AND INFLAMMATION
$298,077Ohio State University · R01 · FY2003 · MH
Implementing Vaccine and Treatment Evaluation Unit (VTEU) Clinical Site
$298,077Karen L. Kotloff · University Of Maryland Baltimore · UM1 · FY2022 · AI
Simulation of Proton Translocation in Biomolecules
$298,061Gregory A. Voth · University Of Chicago · R01 · FY2016 · GM
Natural Killer Cell Responses of Aged Mice to Primary Influenza Infection
$298,011Elizabeth M. Gardner · Michigan State University · R01 · FY2013 · AG
Clinical Core
$297,992Octavio Ramilo · Baylor Research Institute · U19 · FY2011 · AI
U HAWAII COBRE: ADMINISTRATIVE & MENTORING CORE
$297,932Richard Yanagihara · University Of Hawaii At Manoa · P20 · FY2007 · RR
Bacterial Pneumonia Therapeutic Antibody Safety Trial
$297,917Lawrence Michael Kauvar · Trellis Bioscience, Inc. · U44 · FY2024 · AI
Hazardous Materials Worker Health and Safety Training- HDPTP
$297,888Mitchel Rosen · Rutgers Biomedical And Health Sciences · U45 · FY2024 · ES
Rapid, versatile PCR
$297,872Gregory W Faris · Numentus Technologies Inc. · R43 · FY2024 · AI
The Development of a PCR-based Commercial Diagnostic Assay for Avian Influenza A
$297,855Michael A Zoccoli · Applera Corporation · U01 · FY2006 · AI
Role of Toll-like receptors in the generation of acquired immunity
$297,817David Segal · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Pulmonary delivery of a hybrid therapeutic to halt respiratory viral infection
$297,817Joy A Phillips · San Diego State University · R01 · FY2012 · GM
Regulation of antibody-mediated effector functions
$297,692Taia Wang · Stanford University · U19 · FY2025 · AI
High-Expression, Rapid Production of Influenza Vaccines in Cell-Based Systems
$297,690Vitaliy Gavrilyuk · Cdi Bioscience, Inc. · R01 · FY2012 · AI
Screening for Psychosocial Risk in Pediatric Sickle Cell Disease
$297,670Steven Reader · Nemours Children'S Hospital, Delaware · P20 · FY2015 · GM
Lipid Effector Molecules of Innate Immunity: Antimicrobial Cholesteryl Esters
$297,495Edith Porter · California State University Los Angeles · SC1 · FY2011 · GM